Prostaglandins in labor - A translational approach

Frontiers in Bioscience

Volumn 13, Issue 15, 2008, Pages 5794-5809

  Khan, Abdul H ^a   Carson, Ray J ^b   Nelson, Scott M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Institute for Clean Growth and Future Mobility   (United Kingdom)

Author keywords

COX 1; COX 2; Labor; Prostaglandin Dehydrogenase; Prostaglandin Receptors; Prostaglandins; PTGS; Review

Indexed keywords

CYTOKINE; OXYTOCIN; PROSTAGLANDIN; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN SYNTHASE; UTERUS SPASMOLYTIC AGENT;

BIOSYNTHESIS; DRUG EFFECT; FEMALE; HOMEOSTASIS; HUMAN; LABOR; METABOLISM; PHYSIOLOGY; PREGNANCY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CYTOKINES; FEMALE; HOMEOSTASIS; HUMANS; LABOR, OBSTETRIC; OXYTOCIN; PREGNANCY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RECEPTORS, PROSTAGLANDIN; TOCOLYTIC AGENTS;

EID: 52049087561     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3117     Document Type: Review

References (193)

1. D. L. Simmons, R. M. Botting and T. Hla: Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev, 56, 387-437 (2004) (Pubitemid 39096597)
2. W. Gibb: The role of prostaglandins in human parturition. Ann Med, 30, 235-41 (1998) (Pubitemid 28306447)
3. S. B. Abramson, J. Leszczynska-Piziak and G. Weissmann: Arachidonic acid as a second messenger. Interactions with a GTP-binding protein of human neutrophils. J Immunol, 147, 231-6 (1991)
4. Y. Bromberg and E. Pick: Unsaturated fatty acids stimulate NADPH-dependent superoxide production by cell-free system derived from macrophages. Cell Immunol, 88, 213-21 (1984) (Pubitemid 14011449)
5. R. Graber, C. Sumida and E. A. Nunez: Fatty acids and cell signal transduction. J Lipid Mediat Cell Signal, 9, 91-116 (1994) (Pubitemid 24107766)
6. W. Farrugia, M. A. Aitken, F. van Dunne, M. H. Wong, S. P. Brennecke, K. F. Scott and G. E. Rice: Type II phospholipase A2 in human gestational tissues: subcellular distribution of placental immuno-and catalytic activity. Biochim Biophys Acta, 1166, 77-83 (1993) (Pubitemid 23053118)
7. A. Lopez Bernal, G. E. Newman, P. J. Phizackerley, G. Bryant-Greenwood and J. W. Keeling: Human placental phospholipase A2 activity in term and preterm labour. Eur J Obstet Gynecol Reprod Biol, 43, 185-92 (1992)
8. T. Okazaki, N. Sagawa, J. E. Bleasdale, J. R. Okita, P. C. MacDonald and J. M. Johnston: Initiation of human parturition: XIII. Phospholipase C, phospholipase A2, and diacylglycerol lipase activities in fetal membranes and decidua vera tissues from early and late gestation. Biol Reprod, 25, 103-9 (1981) (Pubitemid 11014091)
9. D. M. Slater, S. Zervou and S. Thornton: Prostaglandins and prostanoid receptors in human pregnancy and parturition. J Soc Gynecol Investig, 9, 118-24 (2002) (Pubitemid 34497139)
10. J. D. Clark, L. L. Lin, R. W. Kriz, C. S. Ramesha, L. A. Sultzman, A. Y. Lin, N. Milona and J. L. Knopf: A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell, 65, 1043-51 (1991) (Pubitemid 121001692)
11. M. G. Farina, S. Billi, G. Leguizamon, C. Weissmann, T. Guadagnoli, M. L. Ribeiro and A. M. Franchi: Secretory and cytosolic phospholipase A2 activities and expression are regulated by oxytocin and estradiol during labor. Reproduction, 134, 355-64 (2007) (Pubitemid 47278807)
12. K. A. Freed, E. K. Moses, S. P. Brennecke and G. E. Rice: Differential expression of type II, IV and cytosolic PLA2 messenger RNA in human intrauterine tissues at term. Mol Hum Reprod, 3, 493-9 (1997) (Pubitemid 127509369)
13. M. Koyama, S. Ito, A. Nakajima, K. Shimoya, C. Azuma, N. Suehara, Y. Murata and H. Tojo: Elevations of group II phospholipase A2 concentrations in serum and amniotic fluid in association with preterm labor. Am J Obstet Gynecol, 183, 1537-43 (2000) (Pubitemid 32061221)
14. M. Lappas, M. Permezel, H. M. Georgiou and G. E. Rice: Regulation of phospholipase isozymes by nuclear factor-kappaB in human gestational tissues in vitro. J Clin Endocrinol Metab, 89, 2365-72 (2004) (Pubitemid 38619877)
15. M. Lappas and G. E. Rice: Phospholipase A2 isozymes in pregnancy and parturition. Prostaglandins Leukot Essent Fatty Acids, 70, 87-100 (2004)
16. E. K. Moses, K. A. Freed, S. P. Brennecke and G. E. Rice: Distribution of the phospholipase A2 receptor messenger RNA in human gestational tissues. Placenta, 19, 35-40 (1998) (Pubitemid 28112059)
17. G. E. Rice: Secretory type II phospholipase A2 and the generation of intrauterine signals. Reprod Fertil Dev, 7, 1471-9 (1995) (Pubitemid 26135286)
18. I. Kudo and M. Murakami: Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat, 68-69, 3-58 (2002)
19. M. Lappas, M. Permezel, H. M. Georgiou and G. E. Rice: Type II phospholipase A2 in preterm human gestational tissues. Placenta, 22, 64-9 (2001) (Pubitemid 32124098)
20. J. Balsinde, M. A. Balboa, P. A. Insel and E. A. Dennis: Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol, 39, 175-89 (1999)
21. G. C. Di Renzo, J. M. Johnston, T. Okazaki, J. R. Okita, P. C. MacDonald and J. E. Bleasdale: Phosphatidylinositolspecific phospholipase C in fetal membranes and uterine decidua. J Clin Invest, 67, 847-56 (1981) (Pubitemid 11142377)
22. G. A. Bala, N. R. Thakur and J. E. Bleasdale: Characterization of the major phosphoinositide-specific phospholipase C of human amnion. Biol Reprod, 43, 704-11 (1990) (Pubitemid 20348559)
23. N. V. Chandrasekharan, H. Dai, K. L. Roos, N. K. Evanson, J. Tomsik, T. S. Elton and D. L. Simmons: COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A, 99, 13926-31 (2002) (Pubitemid 35215482)
24. I. Morita: Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat, 68-69, 165-75 (2002) (Pubitemid 35247394)
25. W. L. Smith, D. L. DeWitt and R. M. Garavito: Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem, 69, 145-82 (2000)
26. W. L. Xie, J. G. Chipman, D. L. Robertson, R. L. Erikson and D. L. Simmons: Expression of a mitogenresponsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A, 88, 2692-6 (1991) (Pubitemid 21916484)
27. D. L. DeWitt, E. A. Meade and W. L. Smith: PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs. Am J Med, 95, 40S-44S (1993)
28. T. Hla and K. Neilson: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A, 89, 7384-8 (1992)
29. T. Kosaka, A. Miyata, H. Ihara, S. Hara, T. Sugimoto, O. Takeda, E. Takahashi and T. Tanabe: Characterization of the human gene (PTGS2) encoding prostaglandinendoperoxide synthase 2. Eur J Biochem, 221, 889-97 (1994) (Pubitemid 24146188)
30. J. H. Capdevila, J. D. Morrow, Y. Y. Belosludtsev, D. R. Beauchamp, R. N. DuBois and J. R. Falck: The catalytic outcomes of the constitutive and the mitogen inducible isoforms of prostaglandin H2 synthase are markedly affected by glutathione and glutathione peroxidase(s). Biochemistry, 34, 3325-37 (1995)
31. R. J. Kulmacz and L. H. Wang: Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2. J Biol Chem, 270, 24019-23 (1995)
32. M. Murakami, T. Kambe, S. Shimbara and I. Kudo: Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J Biol Chem, 274, 3103-15 (1999) (Pubitemid 29075398)
33. S. Hutten and R. H. Kehlenbach: CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol, 17, 193-201 (2007) (Pubitemid 46507806)
34. F. Higashino, M. Aoyagi, A. Takahashi, M. Ishino, M. Taoka, T. Isobe, M. Kobayashi, Y. Totsuka, T. Kohgo and M. Shindoh: Adenovirus E4orf6 targets pp32/LANP to control the fate of ARE-containing mRNAs by perturbing the CRM1-dependent mechanism. J Cell Biol, 170, 15-20 (2005) (Pubitemid 40994091)
35. B. C. Jang, U. Munoz-Najar, J. H. Paik, K. Claffey, M. Yoshida and T. Hla: Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression. J Biol Chem, 278, 2773-6 (2003) (Pubitemid 36801177)
36. S. Narumiya, Y. Sugimoto and F. Ushikubi: Prostanoid receptors: structures, properties, and functions. Physiol Rev, 79, 1193-226 (1999) (Pubitemid 29473315)
37. Y. Kanaoka, K. Fujimori, R. Kikuno, Y. Sakaguchi, Y. Urade and O. Hayaishi: Structure and chromosomal localization of human and mouse genes for hematopoietic prostaglandin D synthase. Conservation of the ancestral genomic structure of sigma-class glutathione S-transferase. Eur J Biochem, 267, 3315-22 (2000) (Pubitemid 30341160)
38. Y. Urade and O. Hayaishi: Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim Biophys Acta, 1482, 259-71 (2000)
39. R. J. Helliwell, J. A. Keelan, K. W. Marvin, L. Adams, M. C. Chang, A. Anand, T. A. Sato, S. O'Carroll, T. Chaiworapongsa, R. J. Romero and M. D. Mitchell: Gestational age-dependent up-regulation of prostaglandin D synthase (PGDS) and production of PGDS-derived antiinflammatory prostaglandins in human placenta. J Clin Endocrinol Metab, 91, 597-606 (2006) (Pubitemid 43236931)
40. Y. Shiki, K. Shimoya, Y. Tokugawa, T. Kimura, M. Koyama, C. Azuma, Y. Murata, N. Eguchi, H. Oda and Y. Urade: Changes of lipocalin-type prostaglandin D synthase level during pregnancy. J Obstet Gynaecol Res, 30, 65-70 (2004) (Pubitemid 38405066)
41. M. Murakami and I. Kudo: Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog Lipid Res, 43, 3-35 (2004) (Pubitemid 37433865)
42. M. Murakami, H. Naraba, T. Tanioka, N. Semmyo, Y. Nakatani, F. Kojima, T. Ikeda, M. Fueki, A. Ueno, S. Oh and I. Kudo: Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem, 275, 32783-92 (2000)
43. T. Suzuki-Yamamoto, M. Nishizawa, M. Fukui, E. Okuda-Ashitaka, T. Nakajima, S. Ito and K. Watanabe: cDNA cloning, expression and characterization of human prostaglandin F synthase. FEBS Lett, 462, 335-40 (1999)
44. K. Watanabe, R. Yoshida, T. Shimizu and O. Hayaishi: Enzymatic formation of prostaglandin F2 alpha from prostaglandin H2 and D2. Purification and properties of prostaglandin F synthetase from bovine lung. J Biol Chem, 260, 7035-41 (1985) (Pubitemid 15016094)
45. L. Y. Chen, K. Watanabe and O. Hayaishi: Purification and characterization of prostaglandin F synthase from bovine liver. Arch Biochem Biophys, 296, 17-26 (1992)
46. T. Suzuki, Y. Fujii, M. Miyano, L. Y. Chen, T. Takahashi and K. Watanabe: cDNA cloning, expression, and mutagenesis study of liver-type prostaglandin F synthase. J Biol Chem, 274, 241-8 (1999) (Pubitemid 29035055)
47. C. W. Xiao, J. M. Liu, J. Sirois and A. K. Goff: Regulation of cyclooxygenase-2 and prostaglandin F synthase gene expression by steroid hormones and interferon-tau in bovine endometrial cells. Endocrinology, 139, 2293-9 (1998) (Pubitemid 28513751)
48. C. W. Xiao, B. D. Murphy, J. Sirois and A. K. Goff: Down-regulation of oxytocin-induced cyclooxygenase-2 and prostaglandin F synthase expression by interferon-tau in bovine endometrial cells. Biol Reprod, 60, 656-63 (1999) (Pubitemid 29102397)
49. J. J. Hirst, H. C. Parkington, I. R. Young, H. K. Palliser, K. G. Peri and D. M. Olson: Delay of preterm birth in sheep by THG113.31, a prostaglandin F2alpha receptor antagonist. Am J Obstet Gynecol, 193, 256-66 (2005) (Pubitemid 40991854)
50. S. Hara, A. Miyata, C. Yokoyama, R. Brugger, F. Lottspeich, V. Ullrich and T. Tanabe: Molecular cloning and expression of prostacyclin synthase from endothelial cells. Adv Prostaglandin Thromboxane Leukot Res, 23, 121-3 (1995)
51. K. Ohashi, K. H. Ruan, R. J. Kulmacz, K. K. Wu and L. H. Wang: Primary structure of human thromboxane synthase determined from the cDNA sequence. J Biol Chem, 267, 789-93 (1992)
52. R. F. Shen and H. H. Tai: Thromboxanes: synthase and receptors. J Biomed Sci, 5, 153-72 (1998)
53. C. Yokoyama, A. Miyata, H. Ihara, V. Ullrich and T. Tanabe: Molecular cloning of human platelet thromboxane A synthase. Biochem Biophys Res Commun, 178, 1479-84 (1991)
54. P. Moonen, G. Klok and M. J. Keirse: Immunohistochemical localisation of prostaglandin endoperoxide synthase and prostacyclin synthase in pregnant human myometrium. Eur J Obstet Gynecol Reprod Biol, 19, 151-8 (1985) (Pubitemid 15103984)
55. D. Giannoulias, N. Alfaidy, A. C. Holloway, W. Gibb, M. Sun, S. J. Lye and J. R. Challis: Expression of prostaglandin I(2) synthase, but not prostaglandin E synthase, changes in myometrium of women at term pregnancy. J Clin Endocrinol Metab, 87, 5274-82 (2002) (Pubitemid 35316374)
56. M. L. Swanson, Z. M. Lei, P. H. Swanson, C. V. Rao, S. Narumiya and M. Hirata: The expression of thromboxane A2 synthase and thromboxane A2 receptor gene in human uterus. Biol Reprod, 47, 105-17 (1992)
57. B. Wetzka, W. Schafer, F. Kommoss, H. Bettendorf, R. Nusing, M. Breckwoldt and H. P. Zahradnik: Immunohistochemical localization of thromboxane synthase in human intrauterine tissues. Placenta, 15, 389-98 (1994) (Pubitemid 24213373)
58. A. Avdeef, K. J. Box and K. Takacs-Novak: pH-metric log P. 6. Effects of sodium, potassium, and N-CH3-Dglucamine on the octanol-water partitioning of prostaglandins E1 and E2. J Pharm Sci, 84, 523-9 (1995)
59. T. J. Roseman and S. H. Yalkowsky: Physicochemical properties of prostaglandin F2 alpha (tromethamine salt): solubility behavior, surface properties, and ionization constants. J Pharm Sci, 62, 1680-5 (1973)
60. J. Kang, P. Chapdelaine, P. Y. Laberge and M. A. Fortier: Functional characterization of prostaglandin transporter and terminal prostaglandin synthases during decidualization of human endometrial stromal cells. Hum Reprod, 21, 592-9 (2006) (Pubitemid 43372960)
61. V. L. Schuster: Molecular mechanisms of prostaglandin transport. Annu Rev Physiol, 60, 221-42 (1998) (Pubitemid 28157872)
62. V. L. Schuster: Prostaglandin transport. Prostaglandins Other Lipid Mediat, 68-69, 633-47 (2002) (Pubitemid 35247426)
63. S. Itoh, R. Lu, Y. Bao, J. D. Morrow, L. J. Roberts and V. L. Schuster: Structural determinants of substrates for the prostaglandin transporter PGT. Mol Pharmacol, 50, 738-42 (1996)
64. N. Kanai, R. Lu, J. A. Satriano, Y. Bao, A. W. Wolkoff and V. L. Schuster: Identification and characterization of a prostaglandin transporter. Science, 268, 866-9 (1995)
65. Von U.S. Euler and R. Eliasson: Prostaglandins. Academic Press, New York and London (1967)
66. J. Kang, P. Chapdelaine, J. Parent, E. Madore, P. Y. Laberge and M. A. Fortier: Expression of human prostaglandin transporter in the human endometrium across the menstrual cycle. J Clin Endocrinol Metab, 90, 2308-13 (2005) (Pubitemid 40586278)
67. S. K. Banu, J. A. Arosh, P. Chapdelaine and M. A. Fortier: Expression of prostaglandin transporter in the bovine uterus and fetal membranes during pregnancy. Biol Reprod, 73, 230-6 (2005) (Pubitemid 41024965)
68. Y. Bao, M. L. Pucci, B. S. Chan, R. Lu, S. Ito and V. L. Schuster: Prostaglandin transporter PGT is expressed in cell types that synthesize and release prostanoids. Am J Physiol Renal Physiol, 282, F1103-10 (2002) (Pubitemid 34654476)
69. L. C. Bell-Parikh, T. Ide, J. A. Lawson, P. McNamara, M. Reilly and G. A. FitzGerald: Biosynthesis of 15-deoxydelta12, 14-PGJ2 and the ligation of PPARgamma. J Clin Invest, 112, 945-55 (2003) (Pubitemid 38063752)
70. M. Fukushima: Prostaglandin J2-anti-tumour and antiviral activities and the mechanisms involved. Eicosanoids, 3, 189-99 (1990)
71. Y. Hirata, H. Hayashi, S. Ito, Y. Kikawa, M. Ishibashi, M. Sudo, H. Miyazaki, M. Fukushima, S. Narumiya and O. Hayaishi: Occurrence of 9-deoxy-delta 9, delta 12-13, 14-dihydroprostaglandin D2 in human urine. J Biol Chem, 263, 16619-25 (1988) (Pubitemid 18268840)
72. R. M. Zusman, D. Spector, B. V. Caldwell, L. Speroff, G. Schneider and P. J. Mulbow: The effect of chronic sodium loading and sodium restriction on plasma prostaglandin A, E, and F concentrations in normal humans. J Clin Invest, 52, 1093-8 (1973)
73. M. D. Mitchell, A. P. Flint, J. Bibby, J. Brunt, J. M. Arnold, A. B. Anderson and A. C. Turnbull: Plasma concentrations of prostaglandins during late human pregnancy: influence of normal and preterm labor. J Clin Endocrinol Metab, 46, 947-51 (1978) (Pubitemid 8358361)
74. S. M. Sellers, M. D. Mitchell, J. G. Bibby, A. B. Anderson and A. C. Turnbull: A comparison of plasma prostaglandin levels in term and preterm labour. Br J Obstet Gynaecol, 88, 362-6 (1981) (Pubitemid 11113105)
75. P. C. MacDonald and M. L. Casey: The accumulation of prostaglandins (PG) in amniotic fluid is an aftereffect of labor and not indicative of a role for PGE2 or PGF2 alpha in the initiation of human parturition. J Clin Endocrinol Metab, 76, 1332-9 (1993) (Pubitemid 23155459)
76. H. Giles, M. L. Bolofo, S. J. Lydford and G. R. Martin: A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2. Br J Pharmacol, 104, 541-9 (1991)
77. T. Suzuki-Yamamoto, H. Yokoi, Y. Tsuruo, K. Watanabe and K. Ishimura: Identification of prostaglandin F-producing cells in the liver. Histochem Cell Biol, 112, 451-6 (1999) (Pubitemid 30169594)
78. M. D. Mitchell, M. C. Chang, T. Chaiworapongsa, H. Y. Lan, R. J. Helliwell, R. Romero and T. A. Sato: Identification of 9alpha, 11beta-prostaglandin F2 in human amniotic fluid and characterization of its production by human gestational tissues. J Clin Endocrinol Metab, 90, 4244-8 (2005) (Pubitemid 41058204)
79. E. R. Norwitz, P. M. Starkey, A. Lopez Bernal and A. C. Turnbull: Identification by flow cytometry of the prostaglandin-producing cell populations of term human decidua. J Endocrinol, 131, 327-34 (1991)
80. E. A. Willman and W. P. Collins: Distribution of prostaglandins E2 and F2 alpha within the foetoplacental unit throughout human pregnancy. J Endocrinol, 69, 413-9 (1976)
81. D. M. Olson, K. Skinner and J. R. Challis: Prostaglandin output in relation to parturition by cells dispersed from human intrauterine tissues. J Clin Endocrinol Metab, 57, 694-9 (1983) (Pubitemid 13013523)
82. Y. Sadovsky, D. M. Nelson, L. J. Muglia, G. A. Gross, K. C. Harris, A. Koki, J. L. Masferrer and L. M. Olson: Effective diminution of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2. Am J Obstet Gynecol, 182, 370-6 (2000) (Pubitemid 30127350)
83. A. H. Khan, A. Ashwani, T. Javed, S. M. Nelson and R. J. Carson: Effect of femto to nano molar concentrations of prostaglandin analogues on pregnant rat uterine contractility. Eur J Pharmacol, 581, 185-190 (2008)
84. D. J. Crankshaw and R. Dyal: Effects of some naturally occurring prostanoids and some cyclooxygenase inhibitors on the contractility of the human lower uterine segment in vitro. Can J Physiol Pharmacol, 72, 870-4 (1994) (Pubitemid 24336842)
85. M. P. Embrey and D. L. Morrison: The effect of prostaglandins on human pregnant myometrium in vitro. J Obstet Gynaecol Br Commonw, 75, 829-32 (1968)
86. R. A. Coleman, W. L. Smith and S. Narumiya: International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev, 46, 205-29 (1994) (Pubitemid 24185151)
87. M. Bhattacharya, K. Peri, A. Ribeiro-da-Silva, G. Almazan, H. Shichi, X. Hou, D. R. Varma and S. Chemtob: Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope. J Biol Chem, 274, 15719-24 (1999)
88. M. Kotani, I. Tanaka, Y. Ogawa, T. Usui, N. Tamura, K. Mori, S. Narumiya, T. Yoshimi and K. Nakao: Structural organization of the human prostaglandin EP3 receptor subtype gene (PTGER3). Genomics, 40, 425-34 (1997) (Pubitemid 27136995)
89. A. Schmid, K. H. Thierauch, W. D. Schleuning and H. Dinter: Splice variants of the human EP3 receptor for prostaglandin E2. Eur J Biochem, 228, 23-30 (1995)
90. M. Kotani, I. Tanaka, Y. Ogawa, T. Usui, K. Mori, A. Ichikawa, S. Narumiya, T. Yoshimi and K. Nakao: Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions. Mol Pharmacol, 48, 869-79 (1995)
91. T. Namba, Y. Sugimoto, M. Negishi, A. Irie, F. Ushikubi, A. Kakizuka, S. Ito, A. Ichikawa and S. Narumiya: Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature, 365, 166-70 (1993) (Pubitemid 23282063)
92. S. Astle, S. Thornton and D. M. Slater: Identification and localization of prostaglandin E2 receptors in upper and lower segment human myometrium during pregnancy. Mol Hum Reprod, 11, 279-87 (2005) (Pubitemid 40662813)
93. J. Brodt-Eppley and L. Myatt: Prostaglandin receptors in lower segment myometrium during gestation and labor. Obstet Gynecol, 93, 89-93 (1999)
94. G. C. Smith, W. X. Wu and P. W. Nathanielsz: Effects of gestational age and labor on expression of prostanoid receptor genes in baboon uterus. Biol Reprod, 64, 1131-7 (2001) (Pubitemid 32239183)
95. J. Senior, K. Marshall, R. Sangha, G. S. Baxter and J. K. Clayton: In vitro characterization of prostanoid EP-receptors in the non-pregnant human myometrium. Br J Pharmacol, 102, 747-53 (1991)
96. J. Senior, K. Marshall, R. Sangha and J. K. Clayton: In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br J Pharmacol, 108, 501-6 (1993) (Pubitemid 23032562)
97. J. Senior, R. Sangha, G. S. Baxter, K. Marshall and J. K. Clayton: In vitro characterization of prostanoid FP-, DP-, IP-and TP-receptors on the non-pregnant human myometrium. Br J Pharmacol, 107, 215-21 (1992)
98. T. Matsumoto, N. Sagawa, M. Yoshida, T. Mori, I. Tanaka, M. Mukoyama, M. Kotani and K. Nakao: The prostaglandin E2 and F2 alpha receptor genes are expressed in human myometrium and are downregulated during pregnancy. Biochem Biophys Res Commun, 238, 838-41 (1997) (Pubitemid 27472662)
99. Y. L. Dong and C. Yallampalli: Pregnancy and exogenous steroid treatments modulate the expression of relaxant EP(2) and contractile FP receptors in the rat uterus. Biol Reprod, 62, 533-9 (2000) (Pubitemid 30118291)
100. G. N. Europe-Finner, S. Phaneuf, A. M. Tolkovsky, S. P. Watson and A. Lopez Bernal: Down-regulation of G alpha s in human myometrium in term and preterm labor: a mechanism for parturition. J Clin Endocrinol Metab, 79, 1835-9 (1994)
101. I. Z. MacKenzie and M. P. Embrey: Intravaginal PGE2 gel prior to labor induction. Adv Prostaglandin Thromboxane Res, 8, 1477-81 (1980)
102. T. L. Erkinheimo, K. Saukkonen, K. Narko, J. Jalkanen, O. Ylikorkala and A. Ristimaki: Expression of cyclooxygenase-2 and prostanoid receptors by human myometrium. J Clin Endocrinol Metab, 85, 3468-75 (2000)
103. M. Molnar and F. Hertelendy: PGF2 alpha and PGE2 binding to rat myometrium during gestation, parturition, and postpartum. Am J Physiol, 258, E740-7 (1990) (Pubitemid 20179433)
104. S. S. Bollapragada, R. Youssef, A. H. Khan, F. Jordan, A. Young, I. A. Greer, J. E. Norman and S. M. Nelson: Prostaglandin system gene expression during term labour. J Obstet and Gynaecol, 27, S61 (2007)
105. S. M. Karim, S. D. Sharma, G. M. Filshie, J. A. Salmon and P. A. Ganesan: Termination of pregnancy with prostaglandin analogs. Adv Biosci, 9, 811-30 (1973)
106. M. Y. Dawood: Pharmacologic stimulation of uterine contraction. Semin Perinatol, 19, 73-83 (1995)
107. S. M. Karim: Physiological role of prostaglandins in the control of parturition and menstruation. J Reprod Fertil Suppl, 16, Suppl 16:105-1 (1972)
108. J. W. Aiken: Aspirin and indomethacin prolong parturition in rats: evidence that prostaglandins contribute to expulsion of fetus. Nature, 240, 21-5 (1972)
109. J. R. Vane: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol, 231, 232-5 (1971)
110. V. Curbelo, R. Bejar, K. Benirschke and L. Gluck: Premature labor. I. Prostaglandin precursors in human placental membranes. Obstet Gynecol, 57, 473-8 (1981) (Pubitemid 11147060)
111. S. M. Karim and J. Devlin: Prostaglandin content of amniotic fluid during pregnancy and labour. J Obstet Gynaecol Br Commonw, 74, 230-4 (1967)
112. S. M. Karim and S. D. Sharma: Oral administration of prostaglandins for the induction of labour. Br Med J, 1, 260-2 (1971)
113. D. M. Olson, J. E. Mijovic and D. W. Sadowsky: Control of human parturition. Semin Perinatol, 19, 52-63 (1995)
114. N. Alfaidy, M. Sun, J. R. Challis and W. Gibb: Expression of membrane prostaglandin E synthase in human placenta and fetal membranes and effect of labor. Endocrine, 20, 219-25 (2003) (Pubitemid 36571022)
115. J. W. Meadows, A. L. Eis, D. E. Brockman and L. Myatt: Expression and localization of prostaglandin E synthase isoforms in human fetal membranes in term and preterm labor. J Clin Endocrinol Metab, 88, 433-9 (2003) (Pubitemid 36115199)
116. J. W. Meadows, B. Pitzer, D. E. Brockman and L. Myatt: Differential localization of prostaglandin E synthase isoforms in human placental cell types. Placenta, 25, 259-65 (2004) (Pubitemid 38514934)
117. S. R. Sooranna, P. L. Grigsby, N. Engineer, Z. Liang, K. Sun, L. Myatt and M. R. Johnson: Myometrial prostaglandin E2 synthetic enzyme mRNA expression: spatial and temporal variations with pregnancy and labour. Mol Hum Reprod, 12, 625-31 (2006) (Pubitemid 44605609)
118. S. Astle, R. Newton, S. Thornton, M. Vatish and D. M. Slater: Expression and regulation of prostaglandin E synthase isoforms in human myometrium with labour. Mol Hum Reprod, 13, 69-75 (2007) (Pubitemid 44942726)
119. F. Kojima, S. Kato and S. Kawai: Prostaglandin E synthase in the pathophysiology of arthritis. Fundam Clin Pharmacol, 19, 255-61 (2005) (Pubitemid 40769448)
120. C. H. Egarter and P. Husslein: Biochemistry of myometrial contractility. Baillieres Clin Obstet Gynaecol, 6, 755-69 (1992)
121. J. C. Havelock, P. Keller, N. Muleba, B. A. Mayhew, B. M. Casey, W. E. Rainey and R. A. Word: Human myometrial gene expression before and during parturition. Biol Reprod, 72, 707-19 (2005) (Pubitemid 40279850)
122. D. Giannoulias, F. A. Patel, A. C. Holloway, S. J. Lye, H. H. Tai and J. R. Challis: Differential changes in 15-hydroxyprostaglandin dehydrogenase and prostaglandin H synthase (types I and II) in human pregnant myometrium. J Clin Endocrinol Metab, 87, 1345-52 (2002) (Pubitemid 36121107)
123. K. E. Bethin, Y. Nagai, R. Sladek, M. Asada, Y. Sadovsky, T. J. Hudson and L. J. Muglia: Microarray analysis of uterine gene expression in mouse and human pregnancy. Mol Endocrinol, 17, 1454-69 (2003) (Pubitemid 36930463)
124. D. M. Slater, W. J. Dennes, J. S. Campa, L. Poston and P. R. Bennett: Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy. Mol Hum Reprod, 5, 880-4 (1999) (Pubitemid 29406753)
125. A. R. Belt, J. J. Baldassare, M. Molnar, R. Romero and F. Hertelendy: The nuclear transcription factor NFkappaB mediates interleukin-1beta-induced expression of cyclooxygenase-2 in human myometrial cells. Am J Obstet Gynecol, 181, 359-66 (1999) (Pubitemid 29409914)
126. G. Gross, T. Imamura, S. K. Vogt, D. F. Wozniak, D. M. Nelson, Y. Sadovsky and L. J. Muglia: Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse. Am J Physiol Regul Integr Comp Physiol, 278, R1415-23 (2000) (Pubitemid 30439260)
127. C. Sparey, S. C. Robson, J. Bailey, F. Lyall and G. N. Europe-Finner: The differential expression of myometrial connexin-43, cyclooxygenase-1 and -2, and Gs alpha proteins in the upper and lower segments of the human uterus during pregnancy and labor. J Clin Endocrinol Metab, 84, 1705-10 (1999) (Pubitemid 30644280)
128. R. F. Johnson, C. M. Mitchell, W. B. Giles, A. Bisits and T. Zakar: Mechanisms regulating prostaglandin H2 synthase-2 mRNA level in the amnion and chorion during pregnancy. J Endocrinol, 188, 603-10 (2006)
129. A. Fuentes, E. P. Spaziani and W. F. O'Brien: The expression of cyclooxygenase-2 (COX-2) in amnion and decidua following spontaneous labor. Prostaglandins, 52, 261-7 (1996) (Pubitemid 26384387)
130. D. Slater, W. Dennes, R. Sawdy, V. Allport and P. Bennett: Expression of cyclo-oxygenase types-1 and -2 in human fetal membranes throughout pregnancy. J Mol Endocrinol, 22, 125-30 (1999) (Pubitemid 29193100)
131. J. J. Hirst, F. J. Teixeira, T. Zakar and D. M. Olson: Prostaglandin endoperoxide-H synthase-1 and -2 messenger ribonucleic acid levels in human amnion with spontaneous labor onset. J Clin Endocrinol Metab, 80, 517-23 (1995)
132. T. Lindstrom and P. Bennett: Transcriptional regulation of genes for enzymes of the prostaglandin biosynthetic pathway. Prostaglandins Leukot Essent Fatty Acids, 70, 115-35 (2004) (Pubitemid 38141901)
133. Y. Lee, V. Allport, A. Sykes, T. Lindstrom, D. Slater and P. Bennett: The effects of labour and of interleukin 1 beta upon the expression of nuclear factor kappa B related proteins in human amnion. Mol Hum Reprod, 9, 213-8 (2003) (Pubitemid 36503462)
134. J. A. Loudon, C. L. Elliott, F. Hills and P. R. Bennett: Progesterone represses interleukin-8 and cyclo-oxygenase-2 in human lower segment fibroblast cells and amnion epithelial cells. Biol Reprod, 69, 331-7 (2003) (Pubitemid 36806839)
135. J. C. Condon, D. B. Hardy, K. Kovaric and C. R. Mendelson: Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function. Mol Endocrinol, 20, 764-75 (2006)
136. J. C. Condon, P. Jeyasuria, J. M. Faust, J. W. Wilson and C. R. Mendelson: A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci U S A, 100, 9518-23 (2003) (Pubitemid 37033960)
137. V. C. Allport, D. Pieber, D. M. Slater, R. Newton, J. O. White and P. R. Bennett: Human labour is associated with nuclear factor-kappaB activity which mediates cyclooxygenase-2 expression and is involved with the 'functional progesterone withdrawal'. Mol Hum Reprod, 7, 581-6 (2001) (Pubitemid 32536878)
138. R. T. Okita and J. R. Okita: Prostaglandinmetabolizing enzymes during pregnancy: characterization of NAD(+)-dependent prostaglandin dehydrogenase, carbonyl reductase, and cytochrome P450-dependent prostaglandin omega-hydroxylase. Crit Rev Biochem Mol Biol, 31, 101-26 (1996) (Pubitemid 26139975)
139. P. Y. Cheung and J. R. Challis: Prostaglandin E2 metabolism in the human fetal membranes. Am J Obstet Gynecol, 161, 1580-5 (1989) (Pubitemid 20024036)
140. S. Nakla, K. Skinner, B. F. Mitchell and J. R. Challis: Changes in prostaglandin transfer across human fetal membranes obtained after spontaneous labor. Am J Obstet Gynecol, 155, 1337-41 (1986) (Pubitemid 17201702)
141. M. H. Sullivan, C. K. Roseblade and M. G. Elder: Metabolism of prostaglandin E2 on the fetal and maternal sides of intact fetal membranes. Acta Obstet Gynecol Scand, 70, 425-7 (1991)
142. J. A. McCoshen, D. R. Hoffman, J. V. Kredentser, C. Araneda and J. M. Johnston: The role of fetal membranes in regulating production, transport, and metabolism of prostaglandin E2 during labor. Am J Obstet Gynecol, 163, 1632-40 (1990)
143. R. K. Sangha, J. C. Walton, C. M. Ensor, H. H. Tai and J. R. Challis: Immunohistochemical localization, messenger ribonucleic acid abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labor. J Clin Endocrinol Metab, 78, 982-9 (1994) (Pubitemid 24118100)
144. C. A. van Meir, S. G. Matthews, M. J. Keirse, M. M. Ramirez, A. Bocking and J. R. Challis: 15-hydroxyprostaglandin dehydrogenase: implications in preterm labor with and without ascending infection. J Clin Endocrinol Metab, 82, 969-76 (1997) (Pubitemid 27106620)
145. J. R. G. Challis, S. G. Matthews, W. Gibb and S. J. Lye: Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev, 21, 514-50 (2000)
146. P. R. Bennett, G. V. Chamberlain, L. Patel, M. G. Elder and L. Myatt: Mechanisms of parturition: the transfer of prostaglandin E2 and 5-hydroxyeicosatetraenoic acid across fetal membranes. Am J Obstet Gynecol, 162, 683-7 (1990) (Pubitemid 20116317)
147. N. L. Brown, S. A. Alvi, M. G. Elder, P. R. Bennett and M. H. Sullivan: Interleukin-1beta and bacterial endotoxin change the metabolism of prostaglandins E2 and F2alpha in intact term fetal membranes. Placenta, 19, 625-30 (1998)
148. F. A. Patel and J. R. Challis: Cortisol/progesterone antagonism in regulation of 15-hydroxysteroid dehydrogenase activity and mRNA levels in human
149. J. R. Challis, F. A. Patel and F. Pomini: Prostaglandin dehydrogenase and the initiation of labor. J Perinat Med, 27, 26-34 (1999) (Pubitemid 29145886)
150. S. J. Lye, J. Mitchell, N. Nashman, A. Oldenhof, R. Ou, O. Shynlova and L. Langille: Role of mechanical signals in the onset of term and preterm labor. Front Horm Res, 27, 165-78 (2001) (Pubitemid 33816371)
151. F. K. Kloeck and H. Jung: In vitro release of prostaglandins from the human myometrium under the influence of stretching. Am J Obstet Gynecol, 115, 1066-9 (1973)
152. Y. Manabe, T. Okazaki and A. Takahashi: Prostaglandins E and F in amniotic fluid during stretchinduced cervical softening and labor at term. Gynecol Obstet Invest, 15, 343-50 (1983) (Pubitemid 13098572)
153. Y. Manabe, S. Yoshimura, T. Mori and T. Aso: Plasma levels of 13, 14-dihydro-15-keto prostaglandin F2 alpha, estrogens, and progesterone during stretch-induced labor at term. Prostaglandins, 30, 141-52 (1985) (Pubitemid 15045319)
154. G. Leguizamon, J. Smith, H. Younis, D. M. Nelson and Y. Sadovsky: Enhancement of amniotic cyclooxygenase type 2 activity in women with preterm delivery associated with twins or polyhydramnios. Am J Obstet Gynecol, 184, 117-22 (2001) (Pubitemid 32141653)
155. S. R. Sooranna, Y. Lee, L. U. Kim, A. R. Mohan, P. R. Bennett and M. R. Johnson: Mechanical stretch activates type 2 cyclooxygenase via activator protein-1 transcription factor in human myometrial cells. Mol Hum Reprod, 10, 109-13 (2004) (Pubitemid 38196512)
156. A. R. Mohan, S. R. Sooranna, T. M. Lindstrom, M. R. Johnson and P. R. Bennett: The effect of mechanical stretch on cyclooxygenase type 2 expression and activator protein-1 and nuclear factor-kappaB activity in human amnion cells. Endocrinology, 148, 1850-7 (2007) (Pubitemid 46457115)
157. G. Jenkin: Oxytocin and prostaglandin interactions in pregnancy and at parturition. J Reprod Fertil Suppl, 45, 97-111 (1992)
158. M. Molnar, J. Rigo, Jr., R. Romero and F. Hertelendy: Oxytocin activates mitogen-activated protein kinase and up-regulates cyclooxygenase-2 and prostaglandin production in human myometrial cells. Am J Obstet Gynecol, 181, 42-9 (1999) (Pubitemid 29343329)
159. M. Ivanisevic, J. Djelmis and D. Bukovic: Review on prostaglandin and oxytocin activity in preterm labor. Coll Antropol, 25, 687-94 (2001) (Pubitemid 33661678)
160. H. C. Brummer: Further studies on the interaction between prostaglandins and syntocinon on the isolated pregnant human myometrium. J Obstet Gynaecol Br Commonw, 79, 526-30 (1972)
161. G. E. Rice: Cytokines and the initiation of parturition. Front Horm Res, 27, 113-46 (2001) (Pubitemid 33816369)
162. H. M. Todd, V. L. Dundoo, W. R. Gerber, C. A. Cwiak, J. J. Baldassare and F. Hertelendy: Effect of cytokines on prostaglandin E2 and prostacyclin production in primary cultures of human myometrial cells. J Matern Fetal Med, 5, 161-7 (1996)
163. J. King, V. Flenady, S. Cole and S. Thornton: Cyclooxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst RevCD001992 (2005)
164. R. J. Sawdy, S. Lye, N. M. Fisk and P. R. Bennett: A double-blind randomized study of fetal side effects during and after the short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor. Am J Obstet Gynecol, 188, 1046-51 (2003) (Pubitemid 36530061)
165. C. S. Stika, G. A. Gross, G. Leguizamon, S. Gerber, R. Levy, A. Mathur, L. M. Bernhard, D. M. Nelson and Y. Sadovsky: A prospective randomized safety trial of celecoxib for treatment of preterm labor. Am J Obstet Gynecol, 187, 653-60 (2002)
166. K. M. Groom, A. H. Shennan, B. A. Jones, P. Seed and P. R. Bennett: TOCOX-a randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk. Bjog, 112, 725-30 (2005) (Pubitemid 40852839)
167. R. J. Sawdy, K. M. Groom and P. R. Bennett: Experience of the use of nimesulide, a cyclo-oxygenase-2 selective prostaglandin synthesis inhibitor, in the prevention of preterm labour in 44 high-risk cases. J Obstet Gynaecol, 24, 226-9 (2004) (Pubitemid 38491185)
168. M. M. Slattery and J. J. Morrison: Preterm delivery. Lancet, 360, 1489-97 (2002) (Pubitemid 35356329)
169. J. A. Loudon, K. M. Groom and P. R. Bennett: Prostaglandin inhibitors in preterm labour. Best Pract Res Clin Obstet Gynaecol, 17, 731-44 (2003) (Pubitemid 37173372)
170. Y. Yu and C. D. Funk: A novel genetic model of selective COX-2 inhibition: comparison with COX-2 null mice. Prostaglandins Other Lipid Mediat, 82, 77-84 (2007) (Pubitemid 44880167)
171. Y. Yu, J. Fan, X. S. Chen, D. Wang, A. J. Klein-Szanto, R. L. Campbell, G. A. FitzGerald and C. D. Funk: Genetic model of selective COX2 inhibition reveals novel heterodimer signaling. Nat Med, 12, 699-704 (2006) (Pubitemid 43865241)
172. D. H. Wright, D. Abran, M. Bhattacharya, X. Hou, S. G. Bernier, A. Bouayad, J. C. Fouron, A. Vazquez-Tello, M. H. Beauchamp, R. I. Clyman, K. Peri, D. R. Varma and S. Chemtob: Prostanoid receptors: ontogeny and implications in vascular physiology. Am J Physiol Regul Integr Comp Physiol, 281, R1343-60 (2001)
173. D. M. Olson, D. B. Zaragoza, M. C. Shallow, J. L. Cook, B. F. Mitchell, P. Grigsby and J. Hirst: Myometrial activation and preterm labour: evidence supporting a role for the prostaglandin F receptor-a review. Placenta, 24 Suppl A, S47-54 (2003) (Pubitemid 37184734)
174. K. G. Peri, C. Quiniou, X. Hou, D. Abran, D. R. Varma, W. D. Lubell and S. Chemtob: THG113: a novel selective FP antagonist that delays preterm labor. Semin Perinatol, 26, 389-97 (2002) (Pubitemid 36133536)
175. D. M. Olson and C. Ammann: Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour. Front Biosci, 12, 1329-43 (2007) (Pubitemid 46850641)
176. K. Anwer, C. Oberti, G. J. Perez, N. Perez-Reyes, J. K. McDougall, M. Monga, B. M. Sanborn, E. Stefani and L. Toro: Calcium-activated K+ channels as modulators of human myometrial contractile activity. Am J Physiol, 265, C976-85 (1993)
177. R. N. Khan, B. Matharoo-Ball, S. Arulkumaran and M. L. Ashford: Potassium channels in the human myometrium. Exp Physiol, 86, 255-64 (2001) (Pubitemid 32266460)
178. R. N. Khan, S. K. Smith and M. L. Ashford: Contribution of calcium-sensitive potassium channels to NS1619-induced relaxation in human pregnant myometrium. Hum Reprod, 13, 208-13 (1998) (Pubitemid 28075303)
179. R. N. Khan, S. K. Smith, J. J. Morrison and M. L. Ashford: Properties of large-conductance K+ channels in human myometrium during pregnancy and labour. Proc Biol Sci, 251, 9-15 (1993) (Pubitemid 23068968)
180. R. Schubert and M. T. Nelson: Protein kinases: tuners of the BKCa channel in smooth muscle. Trends Pharmacol Sci, 22, 505-12 (2001) (Pubitemid 32913559)
181. H. C. Doheny, M. J. O'Reilly, D. J. Sexton and J. J. Morrison: THG113.31, a specific PGF2alpha receptor antagonist, induces human myometrial relaxation and BKCa channel activation. Reprod Biol Endocrinol, 5, 10 (2007)
182. S. B. Appleby, A. Ristimaki, K. Neilson, K. Narko and T. Hla: Structure of the human cyclo-oxygenase-2 gene. Biochem J, 302 ( Pt 3), 723-7 (1994) (Pubitemid 24289307)
183. B. S. Fletcher, D. A. Kujubu, D. M. Perrin and H. R. Herschman: Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J Biol Chem, 267, 4338-44 (1992)
184. H. Lim, B. C. Paria, S. K. Das, J. E. Dinchuk, R. Langenbach, J. M. Trzaskos and S. K. Dey: Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell, 91, 197-208 (1997) (Pubitemid 27456387)
185. C. D. Loftin, D. B. Trivedi and R. Langenbach: Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus. J Clin Invest, 110, 549-57 (2002) (Pubitemid 34919709)
186. K. Kubota, T. Kubota, D. Kamei, M. Murakami, I. Kudo, T. Aso and I. Morita: Change in prostaglandin E synthases (PGESs) in microsomal PGES-1 knockout mice in a preterm delivery model. J Endocrinol, 187, 339-45 (2005) (Pubitemid 43020255)
187. J. V. Bonventre, Z. Huang, M. R. Taheri, E. O'Leary, E. Li, M. A. Moskowitz and A. Sapirstein: Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature, 390, 622-5 (1997) (Pubitemid 28016198)
188. N. Uozumi, K. Kume, T. Nagase, N. Nakatani, S. Ishii, F. Tashiro, Y. Komagata, K. Maki, K. Ikuta, Y. Ouchi, J. Miyazaki and T. Shimizu: Role of cytosolic phospholipase A2 in allergic response and parturition. Nature, 390, 618-22 (1997) (Pubitemid 28016197)
189. D. J. Dudley, D. W. Branch, S. S. Edwin and M. D. Mitchell: Induction of preterm birth in mice by RU486. Biol Reprod, 55, 992-5 (1996) (Pubitemid 26346531)
190. F. Ushikubi, Y. Sugimoto, A. Ichikawa and S. Narumiya: Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors. Jpn J Pharmacol, 83, 279-85 (2000)
191. Y. Sugimoto, A. Yamasaki, E. Segi, K. Tsuboi, Y. Aze, T. Nishimura, H. Oida, N. Yoshida, T. Tanaka, M. Katsuyama, K. Hasumoto, T. Murata, M. Hirata, F. Ushikubi, M. Negishi, A. Ichikawa and S. Narumiya: Failure of parturition in mice lacking the prostaglandin F receptor. Science, 277, 681-3 (1997) (Pubitemid 27373912)
192. R. Langenbach, S. G. Morham, H. F. Tiano, C. D. Loftin, B. I. Ghanayem, P. C. Chulada, J. F. Mahler, C. A. Lee, E. H. Goulding, K. D. Kluckman, H. S. Kim and O. Smithies: Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell, 83, 483-92 (1995)
193. H. N. Jabbour and K. J. Sales: Prostaglandin receptor signalling and function in human endometrial pathology. Trends Endocrinol Metab, 15, 398-404 (2004) (Pubitemid 39223347)